Mirus Bio

Is your current #AAV process holding you back? Join Fletcher Malcom at Bio-Expo Live 2024 (hosted by Bioprocess Online) for a presentation exploring the short and long-term impacts of process optimization on your gene therapy pipeline. Topics to be covered: ✅ A proprietary economic model which quantitates the impact of #upstream process optimization with varying #transfection technologies using real world case studies. ✅ Fold improvements in AAV titer and percent full capsids as a result of different transfection technologies with batch cost and cost-per dose comparisons. #upstreampd #bioprocess #bioprocessing #genetherapy #celltherapy #processdevelopment #manufacturing #scaling #gmp

Hey process developers, take the first steps towards optimizing your #upstream process by downloading our white paper about how the RevIT™ AAV Enhancer (paired with our VirusGEN #transfection reagent) can: 📈 Increase your titers and percent-full capsids ✳ Cut pDNA requirements 📉 Lower cost per dose Read it here: https://lnkd.in/eVDNEaEi

Join our team! We are seeking a full-time, onsite #chemist with quality management system experience. This individual contributor position will take a hands-on role in the synthesis and analysis of compounds, and a lead role in streamlining processes, updating work instructions, and improving overall production chemistry processes to support the synthesis and analysis of compounds that are utilized in our products. Is this role a fit for you? Apply today: https://lnkd.in/e_Hn2HzN #biotechcareers #biotechjobs #madisonwi #QMS #quality #mirusbio #transfection #productionchemsitry #lifesciencecareers #lifesciencejobs

If you're at the British Society for Gene and Cell Therapy (BSGCT) annual conference this week, be sure to visit Hayder and check out his poster about improved #AAV manufacturing resulting in higher titers and more percent full capsids! #upstreamprocessing #titers #processdevelopment #bioprocess #bioproduction #celltherapy #genetherapy #cellandgene #bsgct #bsgct2024

Increased Transfection Efficiency Boosts AAV Titers for Gene Therapies by 2–4X While approved therapies have the potential to change lives, they also represent some of the costliest drugs on the market, reflecting in part the cost to produce them. Some of the high production costs are driven by inefficiencies in generating sufficient quantities of AAV particles. In this article experts from Mirus Bio describe an enhancer that is simple to use, easily integrates into existing workflows, and produces high-quality titers across a range of cell growth media.

Missed us at ISCT? We had an incredible time in Vancouver, sharing our latest advancements in #AAV manufacturing. A huge thank you to the ISCT, International Society for Cell & Gene Therapy group for hosting such a fantastic event!   Our poster, titled "Universal AAV Enhancer for Improved Viral Titers, Quality, and Reduced Production Costs Across Suspension HEK Platforms," showcases groundbreaking results to help you: ✅ Boost AAV titers ✅ Cut production costs ✅ Transfection reagent compatibility and comparison ✅ Complex stability to scale your gene therapies   For those who couldn’t attend, we’re excited to make our poster available online. Check it out here: https://lnkd.in/gPDstDYi Let’s continue the conversation and explore how these innovations can drive forward the future of #CellAndGeneTherapy. Be sure to connect with Morrel Gonzalez and Joey Tse to continue your discussion on how to make your science more scalable.   #Bioprocessing #Biotechnology #CellCulture #UpstreamProcessing #ISCT2024

At Mirus Bio, our mission is clear: Deliver Innovation. Empower Discovery. Improve Life. We're thrilled to announce the signing of a definite agreement to join MilliporeSigma to help us to accelerate that mission.   In the words of Mirus Bio CEO, Dale Gordon: “The broad portfolio, scale, and global reach of MilliporeSigma, combined with our leading transfection reagents, will help take our business to even greater heights and allow us to serve more customers, and ultimately patients, worldwide."

We’re live at #ISCT2024! Swing by booth 604 to meet Joey Tse and Morrel Gonzalez and learn how you can optimize and scale your upstream process. #cellandgene #cgt #aav #lentivirus #viralvector #genetherapy #celltherapy

Are you looking to boost your #ViralVector production efficiency? Mirus Bio recently hosted a highly informative webinar where experts shared groundbreaking insights on how to achieve 2-10X higher #AAV titers and percent full capsids. Discover how our innovative transfection solutions and expert support can transform your upstream process development. Watch the webinar on-demand here: https://lnkd.in/ggCrv7gH Join the growing community of scientists optimizing their transfection workflows with Mirus Bio. #GeneTherapy #AAV #Transfection #Biotech #UpstreamProcess #CGT

Are you attending #ISCT2024 next week? Join us at Booth 608 to explore our #transfection solutions and learn how to optimize your #UpstreamProcess. Don't miss our poster presentation (Poster 851) on the "Universal #AAV Enhancer for Improved Viral Titers, Quality, and Reduced Production Costs Across Suspension HEK Platforms." Curious about how you can boost your transfection efficiency? Schedule some time with our experts Joey Tse and Morrel Gonzalez using the link below. They're ready to help you optimize your transfection! https://lnkd.in/e9rXACtj Book your meeting now and ensure you get the most out of this ISCT, International Society for Cell & Gene Therapy event with Mirus Bio's innovative products and expert advice. #AAV #GeneTherapy #CGT